Welcome to 19 Conversations. Today we're asking David Jefferys, Senior Vice President for Global Regulatory, Healthcare Policy and Corporate Affairs, Eisai Europe and Chair of EFPIA's Alzheimer's disease platform and Philip Scheltens, Professor of Neurology and Director of the Alzheimer Centre in Amsterdam "Can we expect a cure for Alzheimer's soon?". Listen to hear their discussion on the challenge and how we're preparing for the future. <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Have you dropped the ball on antimicrobial resistance (AMR)?

Have questions about the healthcare industry? Welcome to 19 Conversations, where we will discuss today’s challenges and how we’re preparing for the future.&nbsp;Presented by the European Federation of Pharmaceutical Industries and Association See acast.com/privacy for privacy and opt-out information.